What one share of AtriCure holds
We are a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib or AF), left atrial appendage (LAA) management and post-operative pain management. Afib is an irregular heartbeat, or arrhythmia, which affects over 59 million people worldwide and is a growing epidemic.
AtriCure’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $11.74 |
|---|---|
| Profit | $0.22 |
| Capex (buildings and equipment) | $0.24 |
| Free cash flow | $1.09 |
| Cash and investments | $3.30 |
| Debt | $1.33 |
| Book value | $10.15 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2009 | $3.74 | −$1.13 | $0.09 | −$0.06 | — | $1.17 |
| 2010 | $3.91 | −$0.25 | $0.12 | −$0.12 | — | $1.07 |
| 2011 | $4.11 | −$0.35 | $0.10 | −$0.22 | — | $0.95 |
| 2012 | $4.34 | −$0.47 | $0.18 | −$0.30 | — | $0.74 |
| 2013 | $4.01 | −$0.56 | $0.14 | −$0.40 | — | $3.12 |
| 2014 | $4.07 | −$0.61 | $0.21 | −$1.03 | — | $4.81 |
| 2015 | $4.62 | −$0.97 | $0.48 | −$0.76 | — | $5.78 |
| 2016 | $4.91 | −$1.05 | $0.24 | −$0.72 | — | $5.05 |
| 2017 | $5.39 | −$0.83 | $0.20 | −$0.47 | — | $4.66 |
| 2018 | $5.92 | −$0.62 | $0.18 | −$0.30 | — | $6.46 |
| 2019 | $6.14 | −$0.94 | $0.32 | −$0.74 | — | $6.24 |
| 2020 | $4.90 | −$1.14 | $0.12 | −$0.60 | — | $9.09 |
| 2021 | $5.96 | $1.09 | $0.21 | −$0.51 | — | $10.51 |
| 2022 | $7.22 | −$1.02 | $0.37 | −$0.85 | — | $9.81 |
| 2023 | $8.62 | −$0.66 | $0.26 | −$0.16 | — | $9.81 |
| 2024 | $9.91 | −$0.95 | $0.24 | $0.02 | — | $9.43 |
| 2025 | $11.19 | −$0.24 | $0.19 | $1.01 | — | $9.88 |
Common questions about AtriCure
How much does one share of AtriCure earn?
Over the last 12 months, each share of AtriCure earned $0.22 of profit on $11.74 of sales, keeping about 2¢ of every $1 (profit margin).
Does AtriCure pay a dividend?
AtriCure didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is AtriCure’s book value per share?
AtriCure’s book value is $10.15 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of AtriCure have?
Each share of AtriCure has $3.30 of cash and investments and $1.33 of debt, as of June 30, 2026.
What is AtriCure’s free cash flow per share?
$1.09 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has AtriCure bought back shares?
AtriCure’s share count rose about 227% from 2009 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.